What are Nuvectis Pharma, Inc.'s total assets?

Nuvectis Pharma, Inc. (NVCT) holds $25.4M in total assets, down 15.8% year over year.

How much cash does Nuvectis Pharma, Inc. have?

Nuvectis Pharma, Inc. holds $25.1M in cash and equivalents.

Can Nuvectis Pharma, Inc. cover its short-term obligations?

Its current ratio is 2.27 — current assets exceed current liabilities.

Where does Nuvectis Pharma, Inc.'s balance sheet data come from?

Every line is extracted from Nuvectis Pharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Nuvectis Pharma, Inc. NVCT Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$25.13M-15.9%	$31.63M+70.7%	$35.44M+106%	$26.79M+47.9%	$29.86M+53.4%
Prepaid expenses and other current assets	$268K-5.6%	$75K+1.4%	$145K+5.1%	$214K+17.6%	$284K+13.6%
Total current assets	$25.4M-15.8%	$31.71M+70.4%	$35.59M+106%	$27.01M+47.6%	$30.15M+52.9%
Total assets	$25.4M-15.8%	$31.71M+70.4%	$35.59M+106%	$27.01M+47.6%	$30.15M+52.9%
Accounts payable	$4.7M+56.9%	$6.27M+151%	$6.44M+185%	$4.98M+170%	$2.99M+70.1%
Accrued expenses	$6.45M+28.0%	$6.91M+24.3%	$5M+32.5%	$5.08M+40.6%	$5.04M+46.1%
Total current liabilities	$11.18M+21.6%	$13.3M+49.5%	$11.58M+83.3%	$10.14M+75.6%	$9.19M+61.5%
Total liabilities	$11.18M+21.6%	$13.3M+49.5%	$11.58M+83.3%	$10.14M+75.6%	$9.19M+61.5%
Additional paid-in capital	$119.96M+20.5%	$118.1M+42.4%	$116.38M+49.2%	$101.78M+35.0%	$99.53M+37.4%
Retained earnings	-$105.74M-34.6%	-$99.69M-36.1%	-$92.37M-37.9%	-$84.91M-35.1%	-$78.58M-34.5%
Total stockholders' equity	$14.22M-32.1%	$18.41M+89.6%	$24.01M+118%	$16.87M+34.7%	$20.95M+49.4%
Total liabilities and stockholders' equity	$25.4M-15.8%	$31.71M+70.4%	$35.59M+106%	$27.01M+47.6%	$30.15M+52.9%
Other current assets	$268K-5.6%	$75K+1.4%	$145K+5.1%	$214K+17.6%	$284K+13.6%
Accrued Manufacturing Costs	$6.45M+28.0%	$6.91M+24.3%	$5M+32.5%	$5.08M+40.6%	$5.04M+46.1%
Other Commercial Liabilities	$36K-95.8%	$115K-86.3%	$65K-77.0%	$2K-99.4%	$865K+78.0%
Accrued Liabilities, Current	$36K-95.8%	$115K-86.3%	$65K-77.0%	$2K-99.4%	$865K+78.0%
Compensation and benefits	$6.45M+28.0%	$6.91M+24.3%	$5M+32.5%	$5.08M+40.6%	$5.04M+46.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Nuvectis Pharma, Inc.'s total assets?: Nuvectis Pharma, Inc. (NVCT) holds $25.4M in total assets, down 15.8% year over year.
How much cash does Nuvectis Pharma, Inc. have?: Nuvectis Pharma, Inc. holds $25.1M in cash and equivalents.
Can Nuvectis Pharma, Inc. cover its short-term obligations?: Its current ratio is 2.27 — current assets exceed current liabilities.
Where does Nuvectis Pharma, Inc.'s balance sheet data come from?: Every line is extracted from Nuvectis Pharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.